(Alliance News) - The board of directors of Kolinpharma Spa on Tuesday evening took note of the voluntary totalitarian takeover bid announced on June 21 by Igea Holding Spa and announced the suspension of the share buyback program initiated on April 21.
Said suspension will operate until the date of completion-or ineffectiveness, as the case may be-of the tender offer.
Kolinpharma closed Wednesday's session flat at EUR9.50 per share.
By Maurizio Carta, Alliance News reporter
Comments and questions to redazione@alliancenews.com
Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.